BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Individualized mRNA Manufacturing GmbH on the domination and profit and loss transfer agreement pursuant to Sec. 293a of the German Stock Corporation Act
English Convenience Translation - the German language joint report is decisive Joint report of the Management Board of BioNTech SE, Mainz, and the management of... | April 13, 2023